{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:21:09Z","timestamp":1792164069485,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.addr.2025.115525","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:11:47Z","timestamp":1737976307000},"page":"115525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases"],"prefix":"10.1016","volume":"218","author":[{"given":"Michal","family":"Izrael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Chebath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kfir","family":"Molakandov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Revel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2008.02.006","article-title":"Capturing pluripotency","volume":"132","author":"Silva","year":"2008","journal-title":"Cell"},{"issue":"5391","key":"10.1016\/j.addr.2025.115525_b0010","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.copbio.2009.09.005","article-title":"New strategies to generate induced pluripotent stem cells","volume":"20","author":"O'Malley","year":"2009","journal-title":"Curr Opin Biotechnol"},{"issue":"22","key":"10.1016\/j.addr.2025.115525_b0025","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1242\/dev.01451","article-title":"Human embryonic stem cells: prospects for development","volume":"131","author":"Pera","year":"2004","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stemcr.2017.05.029","article-title":"Assessing the safety of human pluripotent stem cells and their derivatives for clinical applications","volume":"9","author":"Andrews","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jcb.22775","article-title":"Teratomas from pluripotent stem cells: a clinical hurdle","volume":"111","author":"Fong","year":"2010","journal-title":"J Cell Biochem"},{"issue":"9","key":"10.1016\/j.addr.2025.115525_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045532","article-title":"Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny","volume":"7","author":"Gropp","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12265-008-9062-9","article-title":"Immunogenicity and allogenicity: a challenge of stem cell therapy","volume":"2","author":"Charron","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.addr.2025.115525_b0050","article-title":"Cell type-specific gene expression dynamics during human brain maturation","author":"Steyn","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0055","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-019-14198-8","article-title":"Identification of region-specific astrocyte subtypes at single cell resolution","volume":"11","author":"Batiuk","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41583-024-00806-0","article-title":"Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases","volume":"25","author":"Kampmann","year":"2024","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.addr.2025.115525_b0065","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tins.2021.04.008","article-title":"Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis","volume":"44","author":"Van Harten","year":"2021","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0070","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s13311-019-00782-9","article-title":"Cell-autonomous and non-cell-autonomous pathogenic mechanisms in huntington's disease: insights from in vitro and in vivo models","volume":"16","author":"Creus-Muncunill","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"22","key":"10.1016\/j.addr.2025.115525_b0075","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson's disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2025.115525_b0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front Neurol"},{"issue":"10284","key":"10.1016\/j.addr.2025.115525_b0090","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","article-title":"Age-related macular degeneration","volume":"105","author":"Thomas","year":"2021","journal-title":"Med Clin North Am"},{"issue":"7","key":"10.1016\/j.addr.2025.115525_b0105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2967\/jnumed.121.262239","article-title":"Alzheimer disease: standard of diagnosis, treatment, care, and prevention","volume":"63","author":"Teipel","year":"2022","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ejn.14119","article-title":"L-DOPA for Parkinson's disease-a bittersweet pill","volume":"49","author":"Lane","year":"2019","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1574888X14666190823142911","article-title":"Human pluripotent stem cells in neurodegenerative diseases: potentials, advances and limitations","volume":"15","author":"Kolagar","year":"2020","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jare.2013.04.005","article-title":"Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: a review","volume":"5","author":"Vishwakarma","year":"2014","journal-title":"J Adv Res"},{"key":"10.1016\/j.addr.2025.115525_b0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ymeth.2017.09.007","article-title":"Reprogramming of somatic cells to induced neural stem cells","volume":"133","author":"Shahbazi","year":"2018","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10517-009-0547-6","article-title":"Plasticity of human mesenchymal stem cell phenotype and expression profile under neurogenic conditions","volume":"147","author":"Shakhbazau","year":"2009","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12015-023-10645-8","volume":"20","author":"Saglam-Metiner","year":"2024","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1750-3639.2006.00008.x","article-title":"Neural subtype specification from embryonic stem cells","volume":"16","author":"Zhang","year":"2006","journal-title":"Brain Pathol"},{"issue":"8","key":"10.1016\/j.addr.2025.115525_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells13080671","article-title":"Human-induced pluripotent stem cell-derived neural progenitor cells showed neuronal differentiation, neurite extension, and formation of synaptic structures in rodent ischemic stroke brains","volume":"13","author":"Kanemura","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.addr.2025.115525_b0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.pbr.2016.12.008","article-title":"Regulatory considerations for pluripotent stem cell therapies","volume":"230","author":"Carpenter","year":"2017","journal-title":"Prog Brain Res"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13287-024-04065-9","article-title":"Comparative analysis of regulations and studies on stem cell therapies: focusing on induced pluripotent stem cell (iPSC)-based treatments","volume":"15","author":"Song","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcyt.2022.08.001","article-title":"A risk-based approach for cell line development, manufacturing and characterization of genetically engineered, induced pluripotent stem cell-derived allogeneic cell therapies","volume":"25","author":"Dashnau","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.addr.2025.115525_b0165","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"19","key":"10.1016\/j.addr.2025.115525_b0170","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1523\/JNEUROSCI.0311-05.2005","article-title":"Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury","volume":"25","author":"Keirstead","year":"2005","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.addr.2025.115525_b0175","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2217\/rme.15.57","article-title":"Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury","volume":"10","author":"Priest","year":"2015","journal-title":"Regen Med"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/stem.245","article-title":"Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury","volume":"28","author":"Sharp","year":"2010","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/glia.20127","article-title":"Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation","volume":"49","author":"Nistor","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.addr.2025.115525_b0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-1-61779-201-4_29","article-title":"Derivation of oligodendrocyte progenitor cells from human embryonic stem cells","volume":"767","author":"Sharp","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.addr.2025.115525_b0195","doi-asserted-by":"crossref","DOI":"10.2217\/rme.15.57","article-title":"Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury","author":"Priest","year":"2015","journal-title":"Regen Med"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3171\/2020.12.SPINE201853","article-title":"Safety of direct injection of oligodendrocyte progenitor cells into the spinal cord of uninjured Gottingen minipigs","volume":"35","author":"Fessler","year":"2021","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3171\/2021.12.SPINE21622","article-title":"Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury","volume":"37","author":"McKenna","year":"2022","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"10.1016\/j.addr.2025.115525_b0210","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3171\/2022.5.SPINE22167","article-title":"A phase 1\/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury","volume":"37","author":"Fessler","year":"2022","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.addr.2025.115525_b0215","unstructured":"Zahoor, I., A. Shafi, and E. Haq, Pharmacological Treatment of Parkinson's Disease, in Parkinson's Disease: Pathogenesis and Clinical Aspects, T.B. Stoker and J.C. Greenland, Editors. 2018: Brisbane (AU)."},{"issue":"6","key":"10.1016\/j.addr.2025.115525_b0220","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","article-title":"Long-term health of dopaminergic neuron transplants in Parkinson's disease patients","volume":"7","author":"Hallett","year":"2014","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.addr.2025.115525_b0230","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell-based therapies for Parkinson disease-past insights and future potential","volume":"11","author":"Barker","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"10.1016\/j.addr.2025.115525_b0235","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2025.115525_b0240","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-019-0105-5","article-title":"Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease","volume":"6","author":"Harris","year":"2020","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.addr.2025.115525_b0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-444-59575-1.00011-9","article-title":"Derivation of dopaminergic neurons from pluripotent stem cells","volume":"200","author":"Studer","year":"2012","journal-title":"Prog Brain Res"},{"issue":"7378","key":"10.1016\/j.addr.2025.115525_b0250","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.stem.2021.01.005","article-title":"Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use","volume":"28","author":"Kim","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0260","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1242\/dev.097394","article-title":"How to make a midbrain dopaminergic neuron","volume":"142","author":"Arenas","year":"2015","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.addr.2025.115525_b0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/stmcls\/sxae042","article-title":"Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells","volume":"42","author":"Clark","year":"2024","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0275","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2025.115525_b0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","article-title":"iPS cell-based therapy for Parkinson's disease: a Kyoto trial","volume":"13","author":"Takahashi","year":"2020","journal-title":"Regen Ther"},{"issue":"7669","key":"10.1016\/j.addr.2025.115525_b0285","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0290","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","article-title":"Human clinical-grade parthenogenetic ESC-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson's disease","volume":"11","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0295","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrneurol.2016.140","article-title":"Pathophysiological and diagnostic implications of cortical dysfunction in ALS","volume":"12","author":"Geevasinga","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0300","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3727\/096368915X687769","article-title":"Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease","volume":"24","author":"Gonzalez","year":"2015","journal-title":"Cell Transplant"},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0305","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3727\/096368916X691682","article-title":"Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson's disease","volume":"25","author":"Gonzalez","year":"2016","journal-title":"Cell Transplant"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"20","key":"10.1016\/j.addr.2025.115525_b0315","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0320","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.stem.2010.07.003","article-title":"Graft-induced dyskinesias in Parkinson's disease: what is it all about?","volume":"7","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0325","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gps.4756","article-title":"A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores","volume":"33","author":"Carson","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/WNN.0b013e3181c20de7","article-title":"Verbal and visuospatial memory in lateral onset Parkinson disease: time is of the essence","volume":"23","author":"Foster","year":"2010","journal-title":"Cogn Behav Neurol"},{"issue":"7","key":"10.1016\/j.addr.2025.115525_b0335","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/13854046.2016.1188989","article-title":"Parkinson's disease and the Stroop color word test: processing speed and interference algorithms","volume":"30","author":"Sisco","year":"2016","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1980-57642012DN06010002","article-title":"Cognitive assessment instruments in Parkinson's disease patients undergoing deep brain stimulation","volume":"6","author":"Romann","year":"2012","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.addr.2025.115525_b0345","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fpsyg.2015.00641","article-title":"Assessment of a model for achieving competency in administration and scoring of the WAIS-IV in post-graduate psychology students","volume":"6","author":"Roberts","year":"2015","journal-title":"Front Psychol"},{"issue":"Suppl 1","key":"10.1016\/j.addr.2025.115525_b0350","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/PL00007730","article-title":"PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures","volume":"245","author":"Peto","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.addr.2025.115525_b0355","first-page":"1","article-title":"Preclinical evaluation of transaxial intraputaminal trajectory for enhanced distribution of grafted cells in Parkinson's disease","author":"Emborg","year":"2024","journal-title":"J Neurosurg"},{"issue":"14","key":"10.1016\/j.addr.2025.115525_b0360","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/scd.2018.0107","article-title":"Autologous induced pluripotent stem cell-derived neurons to treat Parkinson's disease","volume":"27","author":"Loring","year":"2018","journal-title":"Stem Cells Dev"},{"issue":"13\u201314","key":"10.1016\/j.addr.2025.115525_b0365","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/scd.2023.0043","article-title":"Neurite outgrowth and gene expression profile correlate with efficacy of human induced pluripotent stem cell-derived dopamine neuron grafts","volume":"32","author":"Hills","year":"2023","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.addr.2025.115525_b0370","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/j.wneu.2022.02.095","article-title":"Initial clinical experience with clearpoint smartframe array-aided stereotactic procedures","volume":"162","author":"Sterk","year":"2022","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","article-title":"Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease","volume":"31","author":"Park","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"9013","key":"10.1016\/j.addr.2025.115525_b0385","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis\/riluzole study group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0390","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14737175.2019.1581610","article-title":"Edaravone for the treatment of amyotrophic lateral sclerosis","volume":"19","author":"Yoshino","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0395","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5692\/clinicalneurol.cn-001000","article-title":"An early history of Japanese amyotrophic lateral sclerosis (ALS) and the current significance","volume":"57","author":"Abe","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"issue":"33","key":"10.1016\/j.addr.2025.115525_b0400","first-page":"5022","article-title":"Astrocytes pathology in ALS: a potential therapeutic target?","volume":"23","author":"Johann","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.addr.2025.115525_b0405","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fnins.2020.00824","article-title":"Rising stars: astrocytes as a therapeutic target for ALS disease","volume":"14","author":"Izrael","year":"2020","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0410","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI71601","article-title":"Emerging mechanisms of molecular pathology in ALS","volume":"125","author":"Peters","year":"2015","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0415","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","article-title":"Cell biology of astrocyte-synapse interactions","volume":"96","author":"Allen","year":"2017","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0420","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/glia.23471","article-title":"Directional coupling of oligodendrocyte connexin-47 and astrocyte connexin-43 gap junctions","volume":"66","author":"Fasciani","year":"2018","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0425","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/bpa.12537","article-title":"Stratification of astrocytes in healthy and diseased brain","volume":"27","author":"Verkhratsky","year":"2017","journal-title":"Brain Pathol"},{"key":"10.1016\/j.addr.2025.115525_b0430","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neures.2017.09.011","article-title":"The multi-dimensional roles of astrocytes in ALS","volume":"126","author":"Yamanaka","year":"2018","journal-title":"Neurosci Res"},{"issue":"8","key":"10.1016\/j.addr.2025.115525_b0435","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1073\/pnas.1222361110","article-title":"Intricate interplay between astrocytes and motor neurons in ALS","volume":"110","author":"Phatnani","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.addr.2025.115525_b0440","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122550","article-title":"How degeneration of cells surrounding motoneurons contributes to amyotrophic lateral sclerosis","volume":"9","author":"Crabe","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","article-title":"Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice","volume":"3","author":"Kondo","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0450","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nn.2210","article-title":"Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease","volume":"11","author":"Lepore","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.addr.2025.115525_b0455","article-title":"Astrocytes in pathogenesis of neurodegenerative diseases and potential: translation into clinic","author":"Izrael","year":"2018","journal-title":"InTechOpen: Astrocyte - Physiology and Pathology"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0460","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-023-03903-3","article-title":"Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx(R)) in ALS patients: phase I\/IIa clinical trial results","volume":"21","author":"Gotkine","year":"2023","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0465","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ICU.0000000000000653","article-title":"The future of retinal imaging","volume":"31","author":"Li","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0470","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.addr.2025.115525_b0475","first-page":"558","article-title":"Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells","volume":"17","author":"Vaajasaari","year":"2011","journal-title":"Mol vis"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/tvst.6.3.17","article-title":"Long-Term efficacy of GMP Grade Xeno-free hESC-derived RPE cells following transplantation","volume":"6","author":"McGill","year":"2017","journal-title":"Transl vis Sci Technol"},{"issue":"35","key":"10.1016\/j.addr.2025.115525_b0485","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1073\/pnas.1422818112","article-title":"Small-molecule-directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells","volume":"112","author":"Maruotti","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addr.2025.115525_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100779","article-title":"Retinal stem cell transplantation: Balancing safety and potential","volume":"75","author":"Singh","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0495","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2009.04.035","article-title":"Generation of retinal cells from mouse and human induced pluripotent stem cells","volume":"458","author":"Hirami","year":"2009","journal-title":"Neurosci Lett"},{"issue":"34","key":"10.1016\/j.addr.2025.115525_b0500","doi-asserted-by":"crossref","first-page":"12769","DOI":"10.1073\/pnas.0601990103","article-title":"Efficient generation of retinal progenitor cells from human embryonic stem cells","volume":"103","author":"Lamba","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nbt1384","article-title":"Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells","volume":"26","author":"Osakada","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"475","key":"10.1016\/j.addr.2025.115525_b0510","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat5580","article-title":"Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs","volume":"11","author":"Sharma","year":"2019","journal-title":"Sci Transl Med"},{"issue":"9817","key":"10.1016\/j.addr.2025.115525_b0515","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0520","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10153","key":"10.1016\/j.addr.2025.115525_b0525","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0530","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0535","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","article-title":"Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options","volume":"101","author":"Tanna","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"9967","key":"10.1016\/j.addr.2025.115525_b0540","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0545","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.stemcr.2015.04.005","article-title":"Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients","volume":"4","author":"Song","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115525_b0550","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-018-0053-y","article-title":"Human embryonic stem cell-derived retinal pigment epithelium transplants as a potential treatment for wet age-related macular degeneration","volume":"4","author":"Liu","year":"2018","journal-title":"Cell Discov"},{"issue":"435","key":"10.1016\/j.addr.2025.115525_b0555","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4097","article-title":"A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration","volume":"10","author":"Kashani","year":"2018","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0560","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"da Cruz","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0565","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.addr.2025.115525_b0570","first-page":"223","article-title":"Population genetic studies of retinitis pigmentosa","volume":"32","author":"Boughman","year":"1980","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.addr.2025.115525_b0575","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-1-40","article-title":"Retinitis pigmentosa","volume":"1","author":"Hamel","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.addr.2025.115525_b0580","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0974-9233.173135","article-title":"Clinical Trials in Retinal Dystrophies","volume":"23","author":"Grob","year":"2016","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"8","key":"10.1016\/j.addr.2025.115525_b0590","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1167\/iovs.10-6329","article-title":"Adult donor rod photoreceptors integrate into the mature mouse retina","volume":"52","author":"Gust","year":"2011","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"6","key":"10.1016\/j.addr.2025.115525_b0595","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1167\/iovs.17-23646","article-title":"Transplanted hESC-derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats","volume":"59","author":"McLelland","year":"2018","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0600","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.stemcr.2014.03.011","article-title":"Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice","volume":"2","author":"Assawachananont","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0605","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.stemcr.2017.03.024","article-title":"iPSC-derived retina transplants improve vision in rd1 end-stage retinal-degeneration mice","volume":"8","author":"Mandai","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115525_b0610","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ebiom.2018.11.028","article-title":"Medium- to long-term survival and functional examination of human iPSC-derived retinas in rat and primate models of retinal degeneration","volume":"39","author":"Tu","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0615","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1073\/pnas.1512590113","article-title":"Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration","volume":"113","author":"Shirai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0620","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.stemcr.2021.02.021","article-title":"Low immunogenicity and immunosuppressive properties of human ESC- and iPSC-derived retinas","volume":"16","author":"Yamasaki","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0625","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s42003-023-04543-5","article-title":"Self-organization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy","volume":"6","author":"Watari","year":"2023","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.addr.2025.115525_b0630","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.stem.2023.11.004","article-title":"Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa","volume":"30","author":"Hirami","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0635","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1167\/iovs.10-6413","article-title":"Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival","volume":"52","author":"Zhu","year":"2011","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0640","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcyt.2024.05.022","article-title":"Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC committee","volume":"26","author":"Madrid","year":"2024","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.addr.2025.115525_b0645","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i11.4784","article-title":"The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy","volume":"11","author":"Moy","year":"2023","journal-title":"Med Res Arch"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0650","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","article-title":"Immunological considerations and challenges for regenerative cellular therapies","volume":"4","author":"Petrus-Reurer","year":"2021","journal-title":"Commun Biol"},{"issue":"6","key":"10.1016\/j.addr.2025.115525_b0655","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s12015-020-10042-5","article-title":"Tumorigenic and immunogenic properties of induced pluripotent stem cells: a promising cancer vaccine","volume":"16","author":"Qiao","year":"2020","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.addr.2025.115525_b0660","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0665","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.addr.2025.115525_b0670","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.stemcr.2024.03.006","article-title":"Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers","volume":"19","author":"Pizzato","year":"2024","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.addr.2025.115525_b0675","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.addr.2025.115525_b0680","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2020.12.001","article-title":"Establishment of universal human embryonic stem cell lines","volume":"230","author":"Kong","year":"2021","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0685","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/s41467-020-16225-5","article-title":"Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson's disease","volume":"11","author":"Tiklova","year":"2020","journal-title":"Nat Commun"},{"issue":"7978","key":"10.1016\/j.addr.2025.115525_b0690","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-023-06473-y","article-title":"Single-cell brain organoid screening identifies developmental defects in autism","volume":"621","author":"Li","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0695","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1038\/s41467-020-17929-4","article-title":"Single cell RNA sequencing identifies early diversity of sensory neurons forming via bi-potential intermediates","volume":"11","author":"Faure","year":"2020","journal-title":"Nat Commun"},{"issue":"7931","key":"10.1016\/j.addr.2025.115525_b0700","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-022-05277-w","article-title":"Maturation and circuit integration of transplanted human cortical organoids","volume":"610","author":"Revah","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0705","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nbt.4127","article-title":"An in vivo model of functional and vascularized human brain organoids","volume":"36","author":"Mansour","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.addr.2025.115525_b0710","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1038\/s41467-022-35536-3","article-title":"Multimodal monitoring of human cortical organoids implanted in mice reveal functional connection with visual cortex","volume":"13","author":"Wilson","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.addr.2025.115525_b0715","article-title":"Exploring the current trends of artificial intelligence in stem cell therapy: a systematic review","volume":"13","author":"Srinivasan","year":"2021","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.addr.2025.115525_b0720","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2174\/1389201021666201007122524","article-title":"A review on the role of artificial intelligence in stem cell therapy: an initiative for modern medicines","volume":"22","author":"Shende","year":"2021","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"10.1016\/j.addr.2025.115525_b0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302537","article-title":"The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: a systematic scoping review","volume":"19","author":"Vo","year":"2024","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.addr.2025.115525_b0730","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/stmcls\/sxad049","article-title":"Artificial intelligence supports automated characterization of differentiated human pluripotent stem cells","volume":"41","author":"Marzec-Schmidt","year":"2023","journal-title":"Stem Cells"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T20:58:34Z","timestamp":1740085114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X25000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":146,"alternative-id":["S0169409X25000109"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2025.115525","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2025.115525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115525"}}